MEDULLARY THYROID CANCER
Clinical trials for MEDULLARY THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new MEDULLARY THYROID CANCER trials appear
Sign up with your email to follow new studies for MEDULLARY THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough cancers: radiation meets targeted drug
Disease control Recruiting nowThis study is testing whether it is safe to combine a new targeted drug called tarlatamab with standard radiation therapy. It is for adults with advanced cancers that have a specific protein called DLL3, including certain lung cancers, melanoma, and others. The main goal is to se…
Matched conditions: MEDULLARY THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists track rare cancer syndrome over years to find better treatments
Knowledge-focused Recruiting nowThis study aims to understand how medullary thyroid cancer and the related MEN2 genetic syndrome develop and change over time in children and adults. Researchers will observe 259 participants who have the condition, tracking their health through regular check-ups, scans, and bloo…
Matched conditions: MEDULLARY THYROID CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC